SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: margie who wrote (4072)4/16/1998 12:24:00 PM
From: Steve Fancy  Read Replies (2) | Respond to of 6136
 
(edited)Margie, I agree with your statement, but also believe this is about all that will hold the company up until they get something else on the market. I think you put way to much emphasis on options expiration...this is not INTC or MSFT and the stock is not part of any index that I'm aware of.

A sign that options expiration was a strong influence IMO is not where the stock closes on expiration day. If the stock moves significantly in one direction before expiration, then reverses course sharply the day or two after expiration with no news then it was likely being manipulated.

The bottom line right now, is a one drug company with increasing competition, who seems to know very little about where their sales are coming from in a market that's likely to correct anytime. The stock may see twenties again before it sees 40.

As you know, I own a reasonable amount of this stock, not to mention options and I have no reason to bad mouth the company. I personally am very disappointed, and like to think I talk the way I feel, not my stock positions. If wish I had listened to the insider selling. These guys were not selling token amounts to cover their children's college tuition.

sf



To: margie who wrote (4072)4/16/1998 5:05:00 PM
From: Brian Malloy  Respond to of 6136
 
Yesteday, there was a rather large put position in the April 40's and the stock was poised to close probably around the $37-38 level on Friday. However, that all disappeared today.

Open interest on Apr 40 puts is down to 140 now, while April 40 calls are at 1,400 contracts or so while the April 35 puts and calls are approximately equal 750 +/-80 contracts.

The bottom line to all of this is that the stock will end up closing between $35-35 1/2 tomorrow.



To: margie who wrote (4072)4/16/1998 7:16:00 PM
From: Paul Barr  Respond to of 6136
 
Margie:

I agree with you 100%. If you had told people a year ago what VIRACEPT and AGPH would have done, they would have thought we were looney.

They have a cancer drug in Phase III right now andmany more in the pipeline.

They only person who has been right all along is L. Moss.

These people who are short term investors, most of this thread, please sell your stock and move on. This complaining is becoming absurd.

Go buy Yahoo!!!

Paul